Actively Recruiting
The Use of Stromal Vascular Fraction for Knee Arthrosis
Led by University Hospital, Ghent · Updated on 2024-11-08
10
Participants Needed
1
Research Sites
223 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.
CONDITIONS
Official Title
The Use of Stromal Vascular Fraction for Knee Arthrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Legal capacity
- Osteochondral lesions
- Inflammatory complaints
- (Peri)tendinitis or tendinopathies and ligamentous injuries
- Impingement complaints
- Arthrofibrosis
- Anterior knee pain
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ GENT
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
Research Team
B
Bernard Depypere, MD
CONTACT
J
Jessie De Kinder
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here